Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders-Reference-Cited by-同舟云学术

Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders

Published:2023-04-11 Issue:7 Volume:51 Page:792-803
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Volak Laurie P.^ORCID,Duevel Heide Marika,Humphreys Sara,Nettleton David,Phipps Colin^ORCID,Pike Andy^ORCID,Rynn Caroline,Scott-Stevens Paul,Zhang Donglu,Zientek Michael

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference50 articles.

1. Solution Conformations Shed Light on PROTAC Cell Permeability;Atilaw;ACS Med Chem Lett,2020

2. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References;Bocci;AAPS J,2022

3. Catalytic in vivo protein knockdown by small-molecule PROTACs

4. PROTAC targeted protein degraders: the past is prologue;Békés;Nat Rev Drug Discov,2022

5. Fundamental aspects of DMPK optimization of targeted protein degraders;Cantrill;Drug Discov Today,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic;Drug Metabolism Reviews;2024-07-26

2. Meeting report: DMPK optimisation strategies and quantitative translational PKPD frameworks to predict human PK and efficacious dose of targeted protein degraders;Xenobiotica;2024-07-12

3. Application of machine learning models for property prediction to targeted protein degraders;Nature Communications;2024-07-09

4. Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia;Journal of Medicinal Chemistry;2024-07-08

5. Metabolism of new drug modalities research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-05